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Abstract hIAPP fibrils are associated with Type-II Diabetes, but the link of hIAPP structure to
islet cell death remains elusive. Here we observe that hIAPP fibrils are cytotoxic to cultured
pancreatic b-cells, leading us to determine the structure and cytotoxicity of protein segments
composing the amyloid spine of hIAPP. Using the cryoEM method MicroED, we discover that one
segment, 19–29 S20G, forms pairs of b-sheets mated by a dry interface that share structural
features with and are similarly cytotoxic to full-length hIAPP fibrils. In contrast, a second segment,
15–25 WT, forms non-toxic labile b-sheets. These segments possess different structures and
cytotoxic effects, however, both can seed full-length hIAPP, and cause hIAPP to take on the
cytotoxic and structural features of that segment. These results suggest that protein segment
structures represent polymorphs of their parent protein and that segment 19–29 S20G may serve
as a model for the toxic spine of hIAPP.
DOI: 10.7554/eLife.19273.001
Introduction
Amyloid fibrils are associated with more than 25 diseases, including Alzheimer’s disease, Parkinson’s
disease, and Type-II Diabetes (T2D) (Eisenberg and Jucker, 2012). The fibrils observed in each dis-
ease are composed of a particular protein; in T2D, amyloid fibrils are composed of human islet amy-
loid polypeptide (hIAPP) (Westermark et al., 1987; Cooper et al., 1988). hIAPP is a 37 residue
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polypeptide hormone that is co-secreted with insulin to modulate glucose levels (Roberts et al.,
1989; Westermark et al., 2011).
Researchers have accumulated substantial evidence for a correlation between hIAPP aggregation
and pancreatic b-cell death in the course of the disease, T2D. Approximately 90% of pancreatic tis-
sue samples taken post-mortem from T2D patients contain islet amyloid primarily composed of
hIAPP (Ho¨ppener et al., 2000). The extent of islet amyloid positively correlates with pancreatic b-
cell loss and insulin dependence (Maloy et al., 1981; Esapa et al., 2005; Jurgens et al., 2011).
Additional support for a link comes from comparison of human and mouse IAPP: mouse IAPP differs
from human IAPP by only six residues, 3 of which are b-strand breaking prolines. Consequently,
mouse IAPP does not aggregate (Nishi et al., 1989; Westermark et al., 1990). Moreover, mice can
be induced to develop islet amyloid and T2D when they are engineered to express human IAPP and
fed a high fat diet (Verchere et al., 1996; Westermark et al., 2000). Perhaps the strongest support
for a link is the mutation in hIAPP, hIAPP-S20G; segments that contain this mutation aggregate
more quickly, contribute to increased pancreatic b-cell apoptosis, and are associated with early
onset T2D in families who carry this lesion (Sakagashira et al., 2000; Cao et al., 2012; Meier et al.,
2016; Sakagashira et al., 1996; Lee et al., 2001; Morita et al., 2011).
Although a link between hIAPP aggregation and pancreatic b-cell death is well established, pre-
cisely which type of hIAPP aggregate contributes to pancreatic b-cell death and insulin dependence
remains undetermined. Using mostly in vitro studies, researchers have presented evidence for toxic-
ity of multiple types of hIAPP aggregates. Early studies suggest that amyloid fibrils are the primary
cytotoxic species because preparations that contain fibrillar hIAPP were more cytotoxic than soluble
preparations of the protein (Lorenzo et al., 1994; Lorenzo and Yankner, 1994; Schubert et al.,
1995; Kapurniotu, 2001). Using cells and transgenic rodents as disease models, other studies found
hIAPP fibrils to be associated with apoptosis, b-cell loss, and T2D severity (O’Brien et al., 1995;
Hiddinga and Eberhardt, 1999; Janson et al., 1996; Hull et al., 2005a, 2005b; Pilkington et al.,
2016). In contrast, some studies show that the process of hIAPP fibril formation, not the amyloid
fibrils themselves, is the source of toxicity (Schlamadinger and Miranker, 2014; Oskarsson et al.,
2015). However, most current research studies suggest soluble pre-fibrillar oligomers are the pri-
mary type of toxic aggregate. Support for oligomers as the primary cytotoxic species comes from
eLife digest In Type-II Diabetes, an individual’s cells fail to respond correctly to the hormone
insulin, leaving them unable to counteract high levels of sugar in the blood. Another hormone,
human islet amyloid polypeptide (hIAPP), works with insulin to regulate blood sugar levels. hIAPP is
an amyloid protein, which means that it can lose its normal structure and form fibrils. Fibrils are
difficult for cells to break down and are often associated with disease. Indeed, fibrils of hIAPP often
form in the pancreas as part of Type-II Diabetes.
Some studies have shown that hIAPP fibrils are toxic to pancreatic cells and worsen the
symptoms of Type-II Diabetes. Others suggest that it is the process of fibril formation that is toxic,
not the fibrils themselves. Although the structures of the fibrils have been described, whether these
structures cause cell toxicity has not been investigated.
Krotee et al. have now explored the structures of two overlapping segments of hIAPP using a
new cryo electron microscopy method called MicroED that is ideal for studying such segments. One
segment, called 19-29 S20G, forms a standard amyloid fibril structure that is similar to the structure
of full-length hIAPP fibrils. Adding these segments to human cells causes similar levels of toxicity as
the full-length hIAPP fibrils. The second segment, called 15-25 WT, forms a non-toxic structure that
is less stable than standard amyloid fibrils.
The results presented by Krotee et al. support the view that standard amyloid fibril structures are
toxic to cells and suggest that 19-29 S20G may be a good model to use when studying how full-
length hIAPP fibrils behave. The structure of 19-29 S20G may also be useful as a template for
designing molecules that block amyloid fibril growth. If amyloid fibrils cause cell toxicity in the
pancreas, then these molecules could be used to treat Type-II Diabetes.
DOI: 10.7554/eLife.19273.002
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the observation of oligomers associated with caspase activity and ER stress, which precede the for-
mation of extracellular amyloid fibrils (Meier et al., 2006; Ritzel et al., 2007; Bram et al., 2014;
Mukherjee et al., 2015; Lin et al., 2007; Huang et al., 2007; Haataja et al., 2008; Abedini et al.,
2016). Several recent studies show that hIAPP fibrils are relatively inert and do not exert obvious
toxicity. Despite these extensive in vitro studies, it is not clear that the toxic aggregates they
describe also elicit toxicity in vivo.
In closer agreement with earlier studies, we find that hIAPP preparations that contain fibrils are
cytotoxic to a rat pancreatic b-cell line, thus motivating us to determine the structure of the spine of
hIAPP fibrils. If fibrils are a bona fide type of toxic aggregate in vivo, then determining the atomic
structure of the spine of hIAPP fibrils is a logical approach for advancing our understanding of dis-
ease-relevant targets (Wiltzius et al., 2008, 2009a; Soriaga et al., 2016). Furthermore, we can uti-
lize atomic structures as templates for structure-based design of novel therapeutics that may protect
against pancreatic b-cell death. Although full-length amyloid proteins have so far been resistant to
crystallization, select protein segments that form the spines of amyloid fibrils do form crystals
(Nelson et al., 2005; Sawaya et al., 2007; Rodriguez et al., 2015). Indeed, the atomic structures of
nearly 90 amyloid spines have been revealed in this manner. Other studies have taken an alternative
approach: they employed solid-state NMR to gain detailed structural insights into hIAPP fibril struc-
ture (Luca et al., 2007; Weirich et al., 2016); some of these structures have spurred successful
inhibitor designs (Mirecka et al., 2016). Here, we use the cryoEM method MicroED to determine
the atomic structure of two 11-residue segments, termed spine segments, that span the amyloid
spine of hIAPP.
Results
hIAPP preparations that contain fibrils are cytotoxic to cultured rat
pancreatic b-cells
To compare the cytotoxic effects of oligomeric and fibrillar hIAPP, we generated hIAPP preparations
that contained either amyloid oligomers or fibrils. We did this by aging the same concentration of
hIAPP for 0 and 24 h time periods. Aging hIAPP for 24 h yielded amyloid fibrils and no detectable
oligomers as assessed by Thioflavin-T (ThT) binding, negative-stain transmission electron microscopy
(TEM), and a dot blot assay using the fibrillar oligomer-sensitive antibody, LOC (Figure 1A). Aging
hIAPP for 0 h, which is a freshly dissolved hIAPP sample, yielded oligomers as assessed by a dot blot
assay using LOC, and no amyloid fibrils (Figure 1—figure supplement 1A). Of note, we probed
both hIAPP preparations with 25 different conformational antibodies that are known to bind soluble
oligomers, but only LOC showed binding to any of our preparations. Although LOC was raised
against hIAPP fibrils (Kayed et al., 2007), studies show that it also recognizes fibrillar oligomers
(Wu et al., 2010), which share structural epitopes with amyloid fibrils and are structurally distinct
from A11-positive pre-fibrillar oligomers.
We observe that hIAPP preparations that contain fibrils are significantly more cytotoxic to rat pan-
creatic b-cells than hIAPP preparations that contain oligomers but no detectable fibrils (Figure 1B
and C). We assayed the cytotoxicity of the hIAPP preparations to Rin5F cells, a rat pancreatic b-cell
line (Gazdar et al., 1980) using two metrics: 3-(4,5-dimethylthiazol-2-yl) 2,5-diphenyltetrazolium
bromide (MTT) dye reduction, an indicator of good metabolic health (Mosmann, 1983; Liu et al.,
1997), and activation of caspase-3/7, an indicator of apoptosis (Budihardjo et al., 1999). Further-
more, the insoluble fraction of the hIAPP 24 h sample, which contains fibrils (Figure 1—figure sup-
plement 1B), is cytotoxic, while the soluble fraction is not (Figure 1D), further suggesting that fibrils
are the toxic aggregate in our studies.
Although we do not detect oligomers in the 24 h sample, we cannot rule out the possibility that it
may contain some undetectable population of slowly forming, yet highly toxic oligomers that associ-
ate with fibrils. Despite this possibility, we chose to focus on studying fibrillar structures of hIAPP.
Selection of amyloid spine segments for structural studies
Given that hIAPP fibrils are cytotoxic, we sought to identify the residues that compose their amyloid
spine. We identified residues 15–29 as the amyloid spine based on several lines of evidence and pre-
vious work by others (Westermark et al., 1990; Moriarty and Raleigh, 1999; Goldsbury et al.,
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Figure 1. Preparations of hIAPP that contain amyloid fibrils are cytotoxic to a rat pancreatic b-cell line. (A) Human IAPP (hIAPP) aged for 24 h contains
amyloid fibrils and no detectable oligomers. Amyloid fibrils were observed using ThT binding and TEM. Oligomers were detected using a dot bot
assay with the polyclonal anti-oligomer antibody, LOC. hIAPP oligomers were used as the positive control for LOC binding. The dashed line on the ThT
binding graph indicates ThT fluorescence of vehicle alone. (B) and (C) hIAPP aged for 24 h is significantly more cytotoxic than hIAPP aged for 0 h. In
Figure 1 continued on next page
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2000; Tenidis et al., 2000). First, the sequence of mouse IAPP (mIAPP), which is non-amyloidogenic,
differs from human IAPP only within this region (Figure 1E). Second, the only known familial disease
mutation in hIAPP, hIAPP-S20G, also occurs within this region (Figure 1E) (Sakagashira et al., 2000;
Cao et al., 2012). Third, previous work by our laboratory has shown that Phe15 may be part of the
amyloid spine because it is required for stabilizing an on-pathway a-helical dimer and mutating this
residue can delay fibril formation (Wiltzius et al., 2009b).
For these reasons, we chose to focus on two overlapping 11-residue segments within this region
of the sequence: residues 19–29 and residues 15–25. We chose to study the WT and early onset
S20G mutation segments (Figure 1F). All four spine segments form amyloid fibrils or crystals (Fig-
ure 1—figure supplement 2) that seed full-length hIAPP fibril formation (Figure 1G, Figure 1—fig-
ure supplement 3), suggesting that the spine segments embody structural characteristics of full-
length hIAPP fibrils.
Segment 19–29 S20G forms pairs of b-sheets tightly mated by a dry
interface
To determine the structure of segment 19–29 S20G, we used Micro-Electron Diffraction (MicroED).
MicroED employs a standard cryo electron microscope (cryoEM) in diffraction mode for data collec-
tion from 3D crystals only a few hundred nanometers thick (Figure 2A; Figure 3A) (Shi et al., 2013;
Nannenga et al., 2014a, 2014b; Hattne et al., 2015; Liu et al., 2016). Such thin crystals are capa-
ble of producing measurable Bragg peaks because electrons interact with matter more strongly than
X-rays. Indeed, we found that the nano-sized 3D crystals used for MicroED produced higher resolu-
tion diffraction than relatively larger crystals suited for structure determination at a microfocus X-ray
beamline (Figure 2A). Evidently, micron-thick needle crystals are sufficient for X-ray structure deter-
mination with six or seven residue peptides, but not for 11-residue peptides. These experiences
closely mirrored those in the determination of the atomic structure of the toxic core of a-synuclein
(Rodriguez et al., 2015), an 11-residue segment that forms the spine of amyloid fibrils associated
with Parkinson’s disease.
The MicroED atomic structure of segment 19–29 S20G reveals pairs of parallel in-register b-sheets
mated face-to-face by interdigitation of side-chains and exclusion of water molecules (Figure 3B
and C;Table 1). This arrangement is termed a class I steric-zipper. Such features are observed for
Figure 1 continued
these experiments, 50 mM human and mouse IAPP were aged for the designated time periods and then they were applied to cells at 5 mM final
concentration. Mouse IAPP (mIAPP), which does not form amyloid fibrils, is not cytotoxic regardless of time period of aging. Black horizontal bars
indicate the median (n = 12–15 across 4–5 biological replicates, each with three technical replicates). (B) Rin5F cells treated with hIAPP aged for 24 h
reduce significantly less MTT dye than Rin5F cells treated with hIAPP aged for 0 h (ns=not significant; ****p<0.0001 using an unpaired t-test with equal
standard deviations). (C) Rin5F cells treated with hIAPP aged for 24 h exhibit significantly higher caspase-3/7 activation than Rin5F cells treated with
hIAPP aged for 0 h. Additionally, Rin5F cells treated with hIAPP aged for 24 h exhibit significantly higher caspase-3/7 activation than vehicle-treated
cells (***p=0.0008 using an ordinary one-way ANOVA), but Rin5F cells treated with hIAPP aged for 0 h do not (p=0.4286 using an ordinary one-way
ANOVA) (ns=not significant; **p=0.0011 using an unpaired t-test with equal standard deviations). (D) The insoluble fraction of hIAPP aged 24 h, which
contains amyloid fibrils and no detectable oligomers, contains the cytotoxic species. Cytotoxicity was measured using MTT dye reduction and detection
of caspase-3/7 activation (****p<0.0001; **p<0.0013; n = 9 across three biological replicates, each with three technical replicates). (E) Amino acid
sequences of human IAPP and mouse IAPP. The location of the early onset familial mutation, S20G, is shown below the human sequence. Red residues
in the mouse sequence differ from the human sequence. The amyloid spine of human IAPP and the corresponding region in the mouse sequence is
enclosed in the gray box. (F). Schematic of protein segments that span the amyloid spine, hereon referred to as spine segments, targeted for
characterization. (G) Fibrils of spine segments seed hIAPP fibril formation, suggesting that spine segments embody structural characteristics of full-
length hIAPP fibrils. 10 mM hIAPP was seeded with 10% (v/v) monomer equivalent of pre-formed, unsonicated seed of each spine segment. mIAPP,
which does not contain amyloid fibrils, does not seed hIAPP fibril formation. Curves show average of 4 technical replicates.
DOI: 10.7554/eLife.19273.003
The following figure supplements are available for figure 1:
Figure supplement 1. Characterization of hIAPP aged for 0 h and the soluble and insoluble fractions of hIAPP aged for 24 h.
DOI: 10.7554/eLife.19273.004
Figure supplement 2. All spine segments form amyloid fibrils or 3D crystals only a few hundred nanometers thick, as observed using TEM.
DOI: 10.7554/eLife.19273.005
Figure supplement 3. Technical replicates and control samples for ThT assay in Figure 1G.
DOI: 10.7554/eLife.19273.006
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amyloid spines of other proteins and have been associated with pathology (Nelson et al., 2005;
Sawaya et al., 2007; Ivanova et al., 2009; Colletier et al., 2011; Liu et al., 2011). This zipper con-
tains a tightly packed hydrophobic core consisting of Phe23, Ala25, and Ile27. Phe23 is the central
and largest contributor the hydrophobic core, consistent with multiple other experiments
(Tenidis et al., 2000; Griffiths et al., 1995; Jack et al., 2006; Madine et al., 2008). The dry inter-
face buries 265 A˚2 of surface area per strand, which equates to 24 A˚2 per residue. This interface is
one of the largest and most complementary of any structurally determined steric-zipper interface
(Supplementary file 1); it has a shape complementary of 0.85. The dry interface is nearly as large as
the toxic core of a-synuclein (Rodriguez et al., 2015), but with higher shape complementarity.
The b-sheets of the 19–29 S20G atomic structure possess a curvature that is not common in
shorter hIAPP protein segments (Wiltzius et al., 2008, 2009a; Soriaga et al., 2015). To assess b-
sheet curvature, we compared the root mean square deviations (RMSD’s) of sheets from planarity
across all hIAPP protein segment atomic structures determined to date (Supplementary file 1). The
19–29 S20G structure ranks in the upper half of the list (Figure 3—figure supplement 2), containing
Figure 2. Bragg peaks produced by MicroED from 3D crystals only a few hundred nanometers thick are observed at higher resolution than peaks
produced by X-ray diffraction at a microfocus beamline from microcrystals 10,000 times larger. (A) 3D crystals of 19–29 S20G (right, inset) diffract to 1.6
A˚ using MicroED, a whole angstrom better resolution than the microcrystals of 19–29 S20G (left, inset). (B) 3D crystals of 15–25 WT (right, inset) diffract
to 1.4 A˚ using MicroED, whereas microcrystals of 15–25 WT diffract to 2.2 A˚ using Microfocus X-rays (left, inset).
DOI: 10.7554/eLife.19273.007
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Figure 3. The MicroED atomic structure of segment 19–29 S20G reveals pairs of b-sheets mated by a dry interface. (A) Electron micrograph of 3D
crystals used for data collection. The red circle represents the area of the crystal used for diffraction. (B) Pairs of b-sheets are oriented face-to-face and
they are tightly mated by a dry interface that excludes water. The dry interface is formed by tightly packed, interdigitating side-chains. This panel shows
5 b-strands or layers along the ‘a’ dimension of the unit cell; the average crystal used for data collection is 10,400 layers long in the ‘a’ dimension. (C)
Orthogonal view of the steric-zipper formed by the dry interface. (D) The similarity between the fiber diffraction pattern calculated from the structure
shown in Panel C and the fiber diffraction observed from full-length hIAPP fibrils supports the dry interface as a model for the amyloid spine of full-
length hIAPP fibrils. Along the meridian (left panel), the dry interface and full-length hIAPP fibrils share reflections at 4.7 A˚ and and 2.4 A˚ (black arrows).
Additionally, along the off-meridonal, the diffraction patterns share a reflection at 3.7 A˚. It is difficult to see the reflection at 2.4 A˚ in the full-length
hIAPP fiber diffraction image, but the reflection is clearly visible in the radial profile in Figure 3—figure supplement 1. Along the equator (right panel),
the dry interface and full-length hIAPP fibrils share reflections at 10.0 A˚ and 5.0 A˚ (black arrows). The right panel is magnified 2X to more clearly show
the low-resolution reflections along the equator.
DOI: 10.7554/eLife.19273.008
The following figure supplements are available for figure 3:
Figure supplement 1. The crystal packing of segment 19–29 S20G reveals a second interface, termed the ‘Back-to-Back’ or wet interface, which does
not form the amyloid spine.
DOI: 10.7554/eLife.19273.009
Figure 3 continued on next page
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both sheet curvature and a sharp kink. Most of the shorter peptides are nearly flat, but some have
sharp kinks. The significance of deviation from planarity is not yet clear.
The similarity between the fiber diffraction pattern calculated from this steric-zipper and the fiber
diffraction pattern collected from full-length hIAPP fibrils tends to validate the 19–29 S20G
atomic structure as a model for the amyloid spine of full-length hIAPP (Figure 3D). The diffraction
patterns share several key features, including reflections at 4.7 A˚ and 2.4 A˚ along the meridian, a
reflection at 3.7 A˚ along the off-meridian (left panel), and reflections at 10.0 A˚ and 5.0 A˚ along the
equator (right panel).
Structural studies performed here and elsewhere by others suggest that 19–29 WT can form a
similar dry interface to the one observed in the 19–29 S20G atomic structure. Radial profiles calcu-
lated from X-ray fiber diffraction of 19–29 WT and 19–29 S20G fibrils show strong reflections in com-
mon at 4.6 A˚, 8.4 A˚ and 8.7 A˚, and 34.7 A˚, indicative of interstrand, intersheet, and proto-filament
spacing, respectively (Figure 3—figure supplement 3). A previous study of 20–29 WT fiber diffrac-
tion revealed comparable reflections, which the authors used to formulate a fibril model of 20–29
WT that roughly agrees with our 19–29 S20G atomic structure (Madine et al., 2008). Our atomic
structure and their model differ by a small shift in registration between sheets, allowing for tighter
packing in the atomic structure. These results are consistent with earlier findings by Cao and co-
workers, who observed that hIAPP-WT fibrils seed hIAPP-S20G fibril formation, thus suggesting a
shared fibrillar structure (Cao et al., 2012).
Although the WT and mutant segments likely form similar structures, the structure of the mutant
segment may be more stable. The stability of the mutant segment may stem from the early onset
Gly20 mutation, which adopts an unusual geometry (j =  101.7˚ and y = 107.5˚) that creates a kink
in the peptide backbone. To investigate this hypothesis, we generated a model of 19–29 WT consist-
ing of a mated pair of ten-stranded sheets. The model was identical to the 19–29 S20G atomic struc-
ture with the exception that we adjusted the backbone torsion angles of Ser20 to comply with the
allowed regions of the Ramachandran plot for a non-glycine residue. We compared the energies of
the WT and S20G structures after minimization with FoldIt (Cooper et al., 2010). The dry interfaces
are nearly identical between the two segments, except near Asn21, where the altered backbone tor-
sion angles break the canonical Asn ladder hydrogen bonding interactions with neighboring Asn21
residues within the sheet and instead, form hydrogen bonds with Ser29 from the opposing sheet.
The alteration separates the pair of sheets by approximately 1.5 A˚ in this region, and therefore the
19–29 S20G structure has a slightly lower energy than 19–29 WT ( 590 REU vs.  535 REU).
Segment 15–25 WT forms an arrangement of labile unmated b-sheets
The atomic structure of segment 15–25 WT, also determined using MicroED (Figure 2B; Figure 4A),
shows an arrangement of unmated b-sheets composed of anti-parallel out-of-register b-strands that
is uncharacteristic of pathogenic amyloid fibrils (Figure 4B;Table 1). Most pathogenic amyloid fibrils
are composed of b-strands that stack perpendicular to the sheet-long axis, but the b-strands in out-
of-register structures stack at an angle. Deviation of strands from the fibril perpendicular is a natural
consequence of the registration shift implied by out-of-register structures. The out-of-register b-
strands are stabilized by extensive hydrogen bonding. Within each sheet, the b-strands form two dis-
tinct, unequal interfaces: a stronger interface with twelve hydrogen bonds, and a weaker interface
with eight hydrogen bonds (Figure 4B). This inequality between interfaces has been observed in
previous examples of out-of-register sheets (Soriaga et al., 2015; Laganowsky et al., 2012;
Liu et al., 2012; Yu et al., 2015). A view down the ‘proto-fibril axis’ of the crystal shows that the
faces of adjacent sheets are wet and overlap only partially (Figure 4C); the asymmetric unit contains
density for seven ordered water molecules and one thiocyanate molecule. The area buried between
Figure 3 continued
Figure supplement 2. Scatter plot of sheet RMSD from planarity values for all hIAPP protein segment structures determined to date.
DOI: 10.7554/eLife.19273.010
Figure supplement 3. 19-29 WT and S20G have similar fibrillar structures.
DOI: 10.7554/eLife.19273.011
Figure supplement 4. Radial profile calculated from the X-ray diffraction pattern given by cytotoxic full-length hIAPP fibrils.
DOI: 10.7554/eLife.19273.012
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adjacent sheets is small (10.7 A˚2 per residue) compared to the average steric-zipper (20.1 A˚2 per res-
idue). Hence, there is no dry interface between adjacent sheets in the crystal, and the structure
seems labile compared to that of 19–29 S20G.
Table 1. Statistics of MicroED data collection and atomic refinement.
Sample 19–29 S20G 15–25 WT
Excitation Voltage (kV) 200 200
Electron Source field emission gun field emission gun
Wavelength (A˚) 0.0251 0.0251
Total dose per crystal (e / A˚2) 3.4 2.9
Frame rate (frame/s) 0.3–0.5 0.3–0.5
Rotation rate (˚/s) 0.3 0.3
# crystals used 6 6
Total angular rotation collected (˚) 68 68
Merging Statistics 19–29 S20G 15–25 WT
space group P212121 P1
Unit cell dimensions
a, b, c (A˚) 4.78, 18.6, 70.8 11.68, 18.18, 19.93
a, b, g (˚) 90, 90, 90 62.8, 88.9, 87.6
Resolution (A˚) 1.9 1.4
Rmerge 10.6% (15.0%) 19.9% (50%)
# of reflections 1380 (221) 9014 (153)
Unique reflections 548 (115) 2180 (84)
Completeness 83% (65%) 75% (35.3%)
Multiplicity 2.5 (1.9) 4.1 (1.8)
I/s 5.65 (3.65) 4.33 (1.10)
CC1/2 (Diederichs, 2013) 98.9% 98.5%
Refinement Statistics 19–29 S20G 15–25 WT
Reflections in working set 546 2177
Reflections in test set 53 218
Rwork
† 22.75% 22.47%
Rfree 27.49% 25.90%
RMSD bonds (A˚) 0.01 0.008
RMSD angles (˚) 1.2 1.2
Ramachandran (%)‡
Favored 100 100
Allowed 0 0
Outliers 0 0
PDB ID code 5KNZ 5KO0
EMDB ID code EMD-8272 EMD-8273
*Highest resolution shell shown in parenthesis.
†
Rfactor ¼ 100x
P
Fobsj j   Fcalcj jj j=
P
jFobsj
Fcalc and Fobs are the calculated and observed structure factor amplitudes, respectively. Rwork refers to the Rfactor
for the data utilized in the refinement and Rfree refers to the Rfactor for 10% of the reflections randomly chosen that
were excluded from the refinement.
‡Percentage of residues in Ramachandran plot regions were determined using Molprobity (Chen et al., 2010).
DOI: 10.7554/eLife.19273.013
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Consistent with our observation of unmated b-sheets in the atomic structure, we observe that 15–
25 WT fibrils are relatively weak and reversible compared to 19–29 S20G fibrils, which possess a
canonical pathogenic amyloid fibril architecture. Turbidity readings followed by negative-stain EM
reveal that 15–25 WT fibrils completely disaggregate in the presence of heat and 1% SDS, but 19–
29 S20G fibrils remain intact in up to 2% SDS (Figure 4—figure supplement 1).
Similar to 19–29 S20G, the 15–25 WT atomic structure reveals curved b-sheets. The sheets pos-
sess one of the highest RMSD’s of sheets from planarity for any hIAPP protein segment structure
determined to date (Supplementary file 1, Figure 4—figure supplement 2).
X-ray fiber diffraction and radial profile analysis of 15–25 WT and 15–25 S20G fibrils indicate they
form structures similar to each other (Figure 4—figure supplement 3). Taken together with the
X-ray fiber diffraction data from the 19–29 segments, we conclude that the early onset S20G muta-
tion does not confer a fibril morphology distinguishable from wild-type.
Structural polymorphs elicit different cytotoxic effects
Next we investigated the cytotoxic effects of the spine segments in order to determine if any of
them were similarly cytotoxic to full-length hIAPP preparations. Although the cytotoxic mechanism
of hIAPP is not fully understood, several reports show hIAPP induces mitochondrial dysfunction,
alters cell metabolism, and initiates activation of pro-apoptotic machinery (Butler et al., 2003;
Mulder and Ling, 2009; Zraika et al., 2010; Magzoub and Miranker, 2012; Tomasello et al.,
2014). Based on these findings, we tested the cytotoxicity of the spine segments using MTT dye
reduction (Mosmann, 1983; Liu and Schubert, 1997) and a FRET-based biosensor to assay altered
metabolism and pro-apoptotic machinery activation (Paulsson et al., 2008), respectively.
Using MTT dye reduction, we observe that the labile 15–25 fibrils are not cytotoxic to HEK293
cells (Figure 5A), whereas 19–29 S20G fibrils have comparable cytotoxicity to full-length hIAPP fibrils
(Figure 5B). To verify the cytotoxic effects of each sample, we examined the morphology of the
treated cells under a light microscope. Additionally, in the context of residues 19–29, the S20G seg-
ment is significantly more cytotoxic than the WT segment, consistent with parent full-length hIAPP
(Sakagashira et al., 2000; Meier et al., 2016) (Figure 5B). We did not detect any oligomers present
in the 15–25 WT or 19–29 S20G fibril samples using the LOC antibody (Figure 5—figure supple-
ment 1).
Based on our examination of the insoluble and soluble fractions of the cytotoxic 19–29 S20G sam-
ple, we determine that the cytotoxicity of 19–29 S20G mainly resides in its fibrillar form. We tested
the cytotoxicity of the total, insoluble and soluble fractions of the 19–29 S20G sample to HEK293
cells using MTT dye reduction. We observe that the insoluble fraction, which contains amyloid fibrils,
is similarly cytotoxic to the total (Figure 5C), just as we observed with full-length hIAPP (Figure 1D,
Figure 1—figure supplement 1B). These results suggest that 19–29 S20G may form the toxic spine
of full-length hIAPP.
Further evidence that 19–29 S20G may form the toxic spine of full-length hIAPP comes from our
observation that ( )-epigallocatechin gallate (EGCG), a flavanol known to mitigate full-length hIAPP
cytotoxicity by preventing hIAPP from forming fibrils (Meng et al., 2010), also mitigates 19–29 S20G
cytotoxicity by preventing it from forming fibrils (Figure 5—figure supplement 2B and C). We
hypothesize that EGCG may mitigate fibril formation of full-length hIAPP and 19–29 S20G by bind-
ing to a common site, such as the dry interface of the amyloid spine. A previous study suggested
EGCG may mitigate hIAPP fibril formation by binding hIAPP via hydrophobic interactions
(Young et al., 2015). Indeed, EGCG does not prevent fibril formation of 15–25 WT, which does not
possess a dry hydrophobic interface (Figure 5—figure supplement 2D). In addition, these results
further support our conclusion that preparations of segment 19–29 S20G that contain fibrils are
cytotoxic.
Next we tested whether the spine segments activate pro-apoptotic machinery using a FRET-
based biosensor assay for monitoring caspase-3 activity in real-time (Paulsson et al., 2008). In this
assay, CHO cells are stably transfected with a construct containing enhanced cyan fluorescent pro-
tein (ECFP) and enhanced yellow fluorescent protein (EYFP) fused by a DEVD linker. FRET signal is
observed by exciting ECFP at 440 nm. In cells undergoing apoptosis, active caspase-3-like proteases
target and cleave the DEVD linker, resulting in loss of FRET signal. Cell viability is measured by moni-
toring the ratio of 540 nm/480 nm, which reports loss of FRET signal and increased caspase-3
activity.
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Using this system, we observe that segment 19–29 S20G elicits the most caspase-dependent
cytotoxicity of the spine segments and segments 15–25 are not cytotoxic (Figure 5D and E). Seg-
ment 19–29 S20G is not as cytotoxic as full-length hIAPP in this assay, possibly because hIAPP inter-
action with heparan sulfate proteoglycans (HSPG) is important for apoptosis induction
(Oskarsson et al., 2015), and residues 1–8, which are missing in all of the spine segments, are
required for hIAPP binding to HSPG’s.
Fibril seeds of 15–25 WT reduce the cytotoxicity of full-length hIAPP
Given that the spine segments seed full-length hIAPP fibril formation and that 19–29 S20G and 15–
25 WT fibrils elicit different cytotoxic effects, we investigated whether seeding with either of the
spine segments alters hIAPP cytotoxicity. To do this, we prepared seeded hIAPP at 10 mM with 10%
monomer equivalent of pre-formed seeds, the same conditions used in the ThT assay in Figure 1G.
For all cytotoxicity assays, we dilute samples 1 to 10 to the concentration specified in culture
medium containing pre-plated cells. Thus, we tested the cytotoxicity of seeded hIAPP at 1 mM in
order to preserve the conditions of the ThT assay.
Using MTT dye reduction, we observe that hIAPP seeded with non-toxic 15–25 WT fibrils is less
cytotoxic than hIAPP alone, but hIAPP seeded with stable, toxic 19–29 S20G fibrils is similarly cyto-
toxic to hIAPP alone (Figure 6). Likewise, hIAPP seeded with stable, toxic 19–29 S20G fibrils is signif-
icantly more cytotoxic than hIAPP seeded with labile, non-toxic 15–25 WT fibrils (Figure 6). Seeds
alone are not cytotoxic, indicating the cytotoxic effects we observe originate from the interaction of
each seed with hIAPP and not the seed alone.
There are two possible explanations for the reduced cytotoxicity of the seeded 15–25 WT sample.
First, the 15–25 WT seeds may seed a non-toxic species of full-length hIAPP, or second, the 15–25
WT seeds may interact with full-length hIAPP in some way that reduces its cytotoxicity.
X-ray fiber diffraction and radial profile analysis of the hIAPP fibrils used in the cytotoxicity assay
reveal that fibrils formed by seeding with stable, toxic 19–29 S20G fibrils have a slightly tighter pack-
ing than fibrils formed by seeding with labile, non-toxic fibrils. hIAPP fibrils formed by seeding with
stable, toxic 19–29 S20G fibrils exhibit reflections indicative of shorter equatorial Bragg spacings
than hIAPP seeded with labile, non-toxic 15–25 WT fibrils (9.0 A˚ versus 10.0 A˚) (Figure 6—figure
supplement 1). The tighter packing of these fibrils may explain their enhanced cytotoxicity. Fiber
diffraction could not be detected from seeds alone prepared under the same conditions.
Discussion
In 1901, when Dr. Eugene Opie first observed islet amyloid in post-mortem pancreata of T2D
patients, he proposed a link between the islet amyloid and T2D (Opie, 1901). Over a century later,
multiple studies have shown an unequivocal link between hIAPP aggregation and T2D, but uncer-
tainty remains about which type of hIAPP aggregate contributes to pancreatic b-cell death. Although
most recent in vitro studies suggest soluble oligomers are the primary type of toxic aggregate, here,
we find hIAPP samples that contain fibrils alter pancreatic b-cell metabolism and activate pro-apo-
ptotic caspases.
These findings motivated us to determine the structure of the spine of hIAPP fibrils and elucidate
structural features important for hIAPP cytotoxicity. To improve our likelihood of crystallization and
structure determination, we selected four protein segments that span the spine. We discovered that
segment 19–29 S20G forms a pair of b-sheets mated at a dry interface, a structure that shares key
features with full-length hIAPP fibrils as described in the following paragraph. What’s more, the
fibrillar form of 19–29 S20G is cytotoxic. In contrast, segment 15–25 WT forms an unusual arrange-
ment of single, out-of-register b-sheets that are not cytotoxic. The divergence in structure and cyto-
toxicity of segments 19–29 S20G and 15–25 WT suggests that strong, stable intermolecular
interactions are important features of cytotoxic amyloid proteins.
The experiments of this study show that the 19–29 S20G atomic structure recapitulates many of
the structural features and cytotoxic properties of hIAPP. First, preparations of 19–29 S20G that con-
tain fibrils are cytotoxic, as is the case for full-length hIAPP. Second, X-ray fiber diffraction calculated
from the dry interface of the 19–29 S20G atomic structure shares key features with fiber diffraction
collected from full-length hIAPP fibrils. Third, segment 19–29 S20G elicits cytotoxicity by altering cell
metabolism and activating pro-apoptotic machinery, mechanisms by which full-length hIAPP fibrils
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Figure 4. Segment 15–25 WT forms an arrangement of unmated b-sheets that is uncharacteristic of pathogenic amyloid fibrils. (A) Electron micrograph
of 3D crystals used for data collection. The red circle represents the area of the crystal used for diffraction. (B) A single b-sheet contains anti-parallel
out-of-register b-strands stabilized by two distinct, unequal interfaces: a stronger interface with twelve hydrogen bonds, and a weaker interface with
eight hydrogen bonds. The b-strands are out-of-register by two residues because Leu16 on the first b-strand is directly above His18 on the third b-
strand. (C) The view down the proto-fibril axis reveals hydrated interfaces between partially overlapping b-sheets. Notice that adjacent b-sheets lack
side-chain interdigitation. Water molecules are shown as cyan spheres. The thiocyanate molecule is highlighted in gold in the central b-sheet and
colored gray in the peripheral b-sheets.
DOI: 10.7554/eLife.19273.014
The following figure supplements are available for figure 4:
Figure supplement 1. 15-25 WT fibrils are relatively weak and reversible compared to 19–29 S20G fibrils.
DOI: 10.7554/eLife.19273.015
Figure supplement 2. Scatter plot of sheet RMSD from planarity values for all hIAPP protein segment structures determined to date.
DOI: 10.7554/eLife.19273.016
Figure supplement 3. 15-25 WT and S20G have similar fibrillar structures.
DOI: 10.7554/eLife.19273.017
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Figure 5. Segment 19–29 S20G forms the toxic core of hIAPP and segments 15–25 are not toxic. (A and B) Fibrils were formed by incubating the spine
segments overnight under quiescent conditions, the same conditions used to prepared full-length hIAPP fibrils. Next, the samples were applied to
HEK293 cells at the specified concentrationsand then cell viability was quantified using MTT dye reduction. Bars show median cell viability; dashed lines
show median cell viability from 10 mM mIAPP and hIAPP. (A) 15–25 WT and 15–25 S20G fibrils are not toxic compared to full-length hIAPP fibrils (n = 12
across four biological replicates, each with three technical replicates). (B) 19–29 WT fibrils are mildly cytotoxic and 19–29 S20G fibrils are significantly
more cytotoxic than 19–29 WT fibrils (****p<0.0001 using a Mann-Whitney U test; n = 12 across four biological replicates, each with three technical
replicates). 19–29 S20G fibrils (10 mM) are similarly cytotoxic to full-length hIAPP fibrils at the same concentration (lower dashed line) (p=0.09 using an
unpaired t-test with equal standard deviations). (C) The insoluble fraction of the 50 mM 19–29 S20G cytotoxic preparation contains the cytotoxic species.
19–29 S20G fibrils were formed overnight at room temperature and then pelleted by centrifugation. The soluble fraction was carefully removed and
then filtered to ensure it contained no insoluble material. The insoluble material was resuspended in its original volume. Each sample was applied to
HEK293 cells and then cell viability was quantified with MTT dye reduction (***p<0.0002 using an ordinary one-way ANOVA; n = 3 technical replicates)
(D) and (E) Using a FRET-based biosensor assay for monitoring caspase-3 activity in real-time, 19–29 S20G fibrils induce the most caspase-3 activity,
whereas segments 15–25 did not induce caspase-3 activity, consistent with the MTT dye reduction assay results. 50 mM of each spine segment seeded
with 166 nM seeds was applied to stably transfected CHO cells. (D) Fold difference was recorded over 24 h. Datapoints represent average fold
difference. The dashed line represents the 16 h mark. (E) Average levels of caspase-3 activation after a 16 h incubation relative to untreated cells
(***p<0.0002; ****p<0.0001 using an ordinary one-way ANOVA, Bonferroni correction; n = 5 technical replicates).
DOI: 10.7554/eLife.19273.018
The following figure supplements are available for figure 5:
Figure supplement 1. Fibrillar samples of 15–25 WT and 19–29 S20G do not contain detectable amyloid oligomers.
DOI: 10.7554/eLife.19273.019
Figure supplement 2. ( )-epigallocatechin gallate (EGCG), a flavanol known to mitigate full-length hIAPP cytotoxicity by preventing it from forming
fibrils, likewise mitigates 19–29 S20G cytotoxicity by preventing it from forming fibrils.
DOI: 10.7554/eLife.19273.020
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are thought to contribute to pancreatic b-cell
death during T2D. Fourth, the early onset S20G
mutation confers greater cytotoxicity within seg-
ment 19–29 and within full-length hIAPP. Last,
EGCG, a flavanol that mitigates full-length hIAPP
fibril formation and cytotoxicity, likewise miti-
gates 19–29 S20G fibril formation and cytotoxic-
ity. These results, taken together with the
canonical pathogenic amyloid fibril architecture
of segment 19–29 S20G, suggest it represents
the toxic amyloid spine of hIAPP.
Our studies begin to provide a framework for
understanding which hIAPP fibril polymorphs
may contribute to pancreatic b-cell death during
T2D. Previous structural studies of hIAPP protein
segments (Wiltzius et al., 2008,
2009a; Soriaga et al., 2015) and full-length
hIAPP (Luca et al., 2007; Weirich et al., 2016;
Goldsbury et al., 1997; Kajava et al., 2005;
Bedrood et al., 2012; Wineman-Fisher et al.,
2015) identified an array of structures with
diverse side-chain and sheet arrangements; the
15 hIAPP protein segment structures that overlap
the hIAPP amyloid spine belong to six different
steric-zipper classes (Figure 7). These multiple
diverse structures suggest there is significant
polymorphism within the hIAPP amyloid spine,
but exactly which of these polymorphs elicit cyto-
toxicity was not known. By studying the struc-
tures and cytotoxic effects of protein segments in
parallel, we identify a cytotoxic hIAPP fibril struc-
ture that may contribute to pancreatic b-cell
death during T2D. Additionally, our studies sug-
gest that not all hIAPP fibril structures are
cytotoxic.
Both atomic structures presented here reveal
a new and potentially important observation:
curved b-sheets. In the dry interface of the 19–29
S20G atomic structure, the curved b-sheets
accommodate the tightly packed hydrophobic
core, which includes a bulky phenylalanine, while
maintaining high shape complementarity and
large buried surface area. Paradoxically, in the
15–25 WT atomic structure, the curved b-sheets
appear to have an opposite effect: the curved b-
sheets appear to prevent adjacent sheets from associating to form a canonical pathogenic amyloid
fibril architecture. In both atomic structures, the effect of the curved b-sheets is dictated by the reg-
istry of adjacent b-sheets (Supplementary file 1, Figure 7).
The 15–25 WT atomic structure joins the recently discovered class of out-of-register protein seg-
ment structures, which exert disparate cytotoxic effects. Here, we show that 15–25 WT is not cyto-
toxic but in contrast, the out-of-register protein segment KDWSFY from b2-microglobulin elicits mild
cytotoxicity (Liu et al., 2012). One notable difference between the two structures is that the 15–25
WT structure is formed of single sheets, while the KDWSFY structure is formed of sheets mated by a
dry interface. The dry interface of the KDWSFY atomic structure results in a higher solvation energy
per strand compared to the 15–25 WT atomic structure (122 cal/mol/strand vs. 19 cal/mol/strand).
Given that cytotoxic structures like 19–29 S20G have relatively high solvation energies per strand
Figure 6. Fibril seeds of 15–25 WT reduce the
cytotoxicity of full-length hIAPP. In this experiment, we
incubated 10 mM hIAPP with or without 10% monomer
equivalent of pre-formed seeds overnight under
quiescent conditions, the same conditions used to
seed full-length hIAPP fibril formation in Figure 1.
Next, we diluted the samples 1 to 10 in culture media
containing pre-plated Rin5F cells. Note: the
concentration of IAPP used in this experiment is less
than the IAPP concentrations used in the cytotoxicity
assays in Figures 1 and 5. hIAPP seeded with stable,
toxic 19–29 S20G fibrils is more cytotoxic to Rin5F cells
than hIAPP seeded with labile, non-toxic 15–25 WT
fibrils. Columns indicate median cell viability (ns = not
significant; **p=0.006; ****p<0.0001 using an unpaired
t-test with equal standard deviations, n = 9 across three
biological replicates, each with three technical
replicates). 19–29 S20G seeds and 15–25 WT seeds
(100 nM each) are not cytotoxic to Rin5F cells.
DOI: 10.7554/eLife.19273.021
The following figure supplement is available for
figure 6:
Figure supplement 1. hIAPP fibrils made by seeding
with each spine segment have slightly different
structural features.
DOI: 10.7554/eLife.19273.022
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(279 cal/mol/strand; Supplementary file 1), this difference may explain the disparate cytotoxic
effects of the two out-of-register structures. However, we need more studies of out-of-register pro-
tein structures and their cognate cytotoxic effects to definitively make this conclusion. The disparate
cytotoxic effects within this structure class lead us to believe that the nature of cytotoxicity is not
simply conferred by in-register or out-of-register structures. As many studies have suggested, there
may be more than one mechanism of amyloid-related toxicity and the different mechanisms may be
catalyzed by different architectures. Alternatively, maybe if additional residues were included, the
anti-parallel out-of-register fiber could be stabilized, thereby increasing its toxicity.
Although the 19–29 WT fibrils prepared in this study appear morphologically similar to 19–29
S20G fibrils, the 19–29 WT fibrils are likely polymorphic and may contain some fraction of fibrils that
are structurally similar to non-toxic 15–25 WT fibrils. Previous structural studies of segment 20–29
WT fibrils show that it forms an array of polymorphs, some of which are similar to the 15–25 WT
atomic structure (Griffiths et al., 1995; Jack et al., 2006; Madine et al., 2008; Ashburn et al.,
1992; Nielsen et al., 2009). Structural polymorphism of 19–29 WT fibrils may explain their lower
cytotoxicity than 19–29 S20G fibrils, which are homogenous in structure.
These findings, expedited by MicroED, may inform our understanding of hIAPP fibril structures
that contribute to pancreatic b-cell death in Type-II Diabetes patients. Going forward, we can use
our toxic amyloid spine model as a template for structure-based design in the effort to develop
much needed therapeutics that protect against pancreatic b-cell death and disease progression
(Sievers et al., 2011; Kahn et al., 2014). In addition, if hIAPP fibrils truly are a major type of toxic
aggregate that contributes to T2D, then raising antibodies against hIAPP fibrils may represent a
Figure 7. Schematic of structural features of all hIAPP protein segment structures determined to date. Parallel (//) or Anti-parallel (A//) refers to the
orientation of b-strands within b-sheets. Registry refers to the translational offset of b-sheets perpendicular to the fiber axis.
DOI: 10.7554/eLife.19273.023
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promising strategy for therapeutic development, especially in light of the recent success of prelimi-
nary studies with antibodies raised against amyloid-b (Sevigny et al., 2016).
Materials and methods
IAPP and protein segments
Human IAPP(1–37)-NH2 wild-type and mouse IAPP(1–37)NH2 wild-type were synthesized by Innopep
(San Diego, CA) and CS Bio (Menlo Park, CA) and purified to greater than 98% purity. Human and
mouse IAPP were prepared by dissolving the lyophilized proteins at 0.25–1 mM in 100% HFIP and
leaving them to dissolve for several hours to ensure complete solubility. Next, the HFIP was removed
with a CentriVap Concentrator (Labconco, Kansas City, MO). After removal of the HFIP, the peptides
were dissolved at 1 mM, 5 mM, or 10 mM in 100% DMSO. The DMSO peptide stocks were diluted
100-fold in filter-sterilized Dulbecco’s PBS (Cat. # 14200–075, Life Technologies, Carlsbad, CA). Sam-
ples were incubated at room temperature for the designated time periods.
All four spine segments were synthesized by GenScript (Piscataway, NJ) and purified to greater
than 98% purity. Fibrils were formed by dissolving lyophilized peptide at 1 mM in PBS and 1%
DMSO.
Crystallization
15-FLVHSSNNFGA-25 (15–25 WT). 15–25 WT was dissolved at 20 mg/ml in ice-cold, nano-pure
water and then spin-filtered. Crystals were grown using the hanging drop vapor diffusion method at
4˚C in 0.35 M NaSCN and 35% MPD. Crystals grew within several hours and reached maximum size
in a week. 3D crystals only a few hundred nanometers thick grew alongside microcrystals in the
same drops.
19-SGNNFGAILSS-29 (19–29 S20G). Microcrystals were grown using the hanging drop vapor dif-
fusion method at 30˚C in 0.2M acetate salts and 40% MPD. 3D crystals only a few hundred nano-
meters thick were grown in batch by dissolving lyophilized peptide at 1 mM in PBS and 1% DMSO
without seeding. Crystals grew on the bench top at room temperature in several hours.
MicroED data collection
The procedures for MicroED data collection and processing largely follow published procedures
(Hattne et al., 2015; Shi et al., 2016). Briefly, a 2–3 mL drop of crystals in suspension was deposited
onto a Quantifoil holey-carbon EM grid then blotted and vitrified by plunging into liquid ethane
using a Vitrobot Mark IV (FEI, Hillsboro, OR). Blotting times and forces were optimized to keep a
desired concentration of crystals on the grid and to avoid damaging the crystals. Frozen grids were
then either immediately transferred to liquid nitrogen for storage or placed into a Gatan 626 cryo-
holder for imaging. Images and diffraction patterns were collected from crystals using an FEG-
equipped FEI Tecnai F20 TEM operating at 200 kV and fitted with a bottom mount TVIPS TemCam-
F416 CMOS-based camera. Diffraction patterns were recorded by operating the detector in a movie
mode termed ‘rolling shutter’ with 22 pixel binning (Nannenga et al., 2014b). Exposure times for
these images were either 2 or 3 s per frame. During each exposure, crystals were continuously unidi-
rectionally rotated within the electron beam at a fixed rate of 0.3 degrees per second, correspond-
ing to a fixed angular wedge of 0.6 or 0.9 degrees per frame.
Crystals that appeared visually undistorted and that were 100–300 nm thick produced the best
diffraction. Datasets from individual crystals were merged to improve completeness and redundancy.
Each crystal dataset spanned a wedge of reciprocal space ranging from 40–80˚. We used a selected
area aperture of approximately 1 mm. The geometry detailed above equates to an electron dose
rate of less than 0.01 e /A˚2 per second being deposited onto our crystals.
Measured diffraction images were converted from TVIPS format into SMV crystallographic format,
using in-house software (available for download at http://cryoem.janelia.org/downloads)
(Hattne et al., 2015).
We used XDS to index and integrate the diffraction images and XSCALE (Kabsch, 2010) for
merging and scaling together datasets originating from different crystals.
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For 19–29 S20G, data from six crystals were merged to assemble the dataset used for molecular
replacement. Of note, the resolution was cut off at 1.9 A˚ to facilitate subsequent rounds of structure
refinement.
For, 15–25 WT, data from six crystals were merged to assemble the dataset used for molecular
replacement. Of note, the diffraction pattern from the 15-25 WT crystals diffracted with MicroED
reveal a pseudo two-fold symmetry. In line with this observation, we indexed and integrated the dif-
fraction images with space group C2, but the datasets had relatively poor statistics compared to the
P1 datasets and our attempts at refining molecular replacement solutions from the C2 datasets
failed.
Structure determination
19–29 S20G. We determined the structure using molecular replacement. An idealized 7-residue
poly-alanine strand led us to our atomic model. The solution was identified using Phaser
(McCoy, 2007). A dataset merged from six crystals was used to identify the initial model, but subse-
quent rounds of model building and refinement were carried out using a dataset from a single crys-
tal. Free R flags were copied over from the dataset merged from six crystals to the single crystal
dataset. Subsequent rounds of model building and refinement were carried out using COOT and
Phenix, respectively (Emsley and Cowtan, 2004; McCoy et al., 2005). Electron scattering factors
were used for refinement.
15–25 WT. We determined the structure using molecular replacement. Dozens of search models
were used, but an out-of-register b-strand model led us to our solution. The solution was identified
using Phaser (McCoy, 2007). Subsequent rounds of model building and refinement were carried out
using COOT and Phenix, respectively (Emsley and Cowtan, 2004; McCoy et al., 2005). Electron
scattering factors were used for refinement. To aid in model building, we used a feature enhanced
map (FEM), which sharpens B factors at high resolution (Afonine et al., 2015).
Calculations of the area buried and shape complementarity (SC) were performed with AREAIMOL
(Lee and Richards, 1971; Collaborative Computational Project, Number 4, 1994) and SC (Con-
nolly, 1983; Richards, 1977; Lawrence and Colman, 1993), respectively.
ThT binding
30 mL of human and mouse IAPP preparations used in the cytotoxicity assays in Figure 1 were pipet-
ted into a black-wall 384-well plate and then mixed with 3 mL of 1 mM Thioflavin-T (ThT). Fluores-
cence was recorded with an excitation wavelength of 444 nm and an emission wavelength of 482
nm.
Dot blot assay
1 mL of each sample generated for cytotoxicity assays in Figure 1 and Figure 5A and B was applied
to a nitrocellulose membrane (Cat. # 162–0146, BioRad, Hercules, CA). Next, the membrane was
blocked in 5% (w/v) nonfat dry milk in PBS-T (T = 0.1% (v/v) Tween-20 (Cat. #BP337-500, Fisher)) for
1 hr at room temperature. After blocking, the membrane was incubated with a 1:100 dilution of
LOC polyclonal rabbit serum (Pacific Immunology, Ramona, CA) in 5% (w/v) milk in PBS-T at 4˚C
overnight. The membrane was washed in PBS-T for 10 min three times, and then incubated with
anti-rabbit secondary antibody (RRID:AB_2307391; Cat. #111-035-144, Jackson ImmunoResearch,
West Grove, PA) diluted 1:10,000 in PBS-T for 1 hr at RT. The membrane was washed three more
times, and then the signal was developed with Clarity Western ECL Substrate (Cat. #170–5061, Bio-
Rad) and documented with a CCD camera. Exposures ranging from 5 s to 5 min were collected, but
the 5 min exposure was used in all figures.
Imaging and negative stain transmission electron microscopy
Samples were spotted onto grids (holey or non-holey) and allowed to settle on the grid for 160 to
180 s. Remaining liquid was wicked off and grids were left to dry before analyzing. Sample grids
were analyzed on the TF20 Electron Microscope (FEI, Hillsboro, OR). Images were collected at 3500
or 6000x magnification with an additional 1.4x post-column magnification and recorded using a
TIETZ F415MP 16 megapixel CCD camera.
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Samples for negative-stain EM were spotted on non-holey carbon-coated grids andallowed to
settle on the grid for 160 to 180 s. Remaining liquid was wicked off and then 2% uranyl acetate was
applied to the grid. After 1 min, the uranyl acetate was wicked off. The grids were left to dry before
analyzing on the T12 Electron Microscope (FEI). Images were collected at 3,200 or 15,000x magnifi-
cation and recorded using a Gatan 2kX2k CCD camera.
Cell culture
Rin5F cells were purchased from ATCC (RRID:CVCL_2177; Cat. # CRL-2058, Manassas, VA). Cells
were cultured in RPMI media (ATCC, Cat. # 30–2001) plus 10% heat-inactivated fetal bovine serum.
Cells were cultured at 37˚C in a 5% CO2 incubator. They tested negative for mycoplasma using a
MycoAlert PLUS Detection Kit (Cat. #: LT07-701, Lonza, Switzerland) and they were authenticated
using Cytochrome C Oxidase 1 (COX1) gene analysis by Laragen (Culver City, CA).
HEK293 c18 cells (hereon referred to as HEK293) were a gift from Carol Eng in the laboratory of
Arnold J. Berk at UCLA, but they were originally purchased from ATCC (RRID:CVCL_6974). Cells
were cultured in DMEM media (Cat. # 11965–092, Life Technologies) plus 10% heat-inactivated fetal
bovine serum and 1% pen-strep (Life Technologies). Cells were cultured at 37˚C in a 5% CO2 incuba-
tor. They tested negative for mycoplasma using a MycoAlert PLUS Detection Kit and they were
authenticated using STR profiling (Laragen).
CHO cells were purchased from ATCC (RRID:CVCL_0214; Cat. #: CCL-61). Cells were cultured in
RPMI 1640 with 11 mM glucose (Sigma) with 10% FBS, and 1% pen-strep. Cells were cultured at
37˚C in a 5% CO2 incubator. They tested negative for mycoplasma using a PCR-based method and
they were authenticated using mRNA analysis.
Spine segment fibril formation
Spine segments were dissolved at 1 mM in PBS with 1% DMSO. Samples were incubated at room
temperature for 15 hr or up to one week under quiescent conditions to form fibrils. The presence of
fibrils was confirmed with electron microscopy. Fibril samples were diluted appropriately for cell via-
bility assays and fibril formation assays.
Fiber diffraction and radial profile analysis
Fibrils were spun down and washed with water three times to remove any salt. Fibrils of spine seg-
ments were spun down using a tabletop microfuge. Full-length hIAPP fibrils and spine segment
seeds were spun down using an Airfuge Ultracentrifuge set at 75,000 rpm for 1 hr (Beckman-Coulter,
Brea, CA). The samples were concentrated 10x in water and applied between two capillary ends and
then the samples were left to dry overnight. Dried fibrils of spine segments and full-length hIAPP in
Figure 3D were analyzed with a RIGAKU R-AXIS HTC imaging plate detector using Cu K(alpha) radi-
ation from a FRE+ rotating anode generator with VARIMAX HR confocal optics (Rigaku, Tokyo,
Japan). Fiber diffraction from full-length hIAPP fibrils used in Figure 6 was recorded by an ADSC
Q315 CCD detector at the Advanced Photon Source 24-ID-E beamline (Argonne, IL).
Radial profiles were calculated using a program written in-house. The program calculates the
average intensity as a function of distance from the beam center.
Thioflavin-T assays
Thioflavin-T (ThT) assays were performed in black 96-well plates (Nunc, Rochester, NY) sealed with
UV optical tape. hIAPP and mIAPP were dissolved at 1 mM in 100% HFIP. The peptides were then
diluted 100-fold in 20 mM sodium acetate pH 6.5 and 10 mM ThT. Unsonicated fibril seeds were
added at 1 mM monomer equivalent concentration (10% v/v). ThT fluorescence was recorded with
excitation and emission of 444 nm and 482 nm, respectively, using a SpectraMax M5 (Molecular
Devices, Sunnyvale, CA). Experiments were performed in quadruplicate and readings were recorded
every 3 min.
Model building and energy analysis of 19–29 WT and 19–29 S20G
To investigate whether 19–29 WT could form a similar structure to 19–29 S20G, we modeled a serine
at position 20 in the 19–29 S20G atomic structure. We adjusted the backbone torsion angles so that
they fell within the ‘allowed’ regions of the Ramachandran plot for a non-glycine residue
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(Emsley and Cowtan, 2004). We performed energy minimization using FoldIt (RRID:SCR_003788)
(Cooper et al., 2010) and compared the energies of the resulting models of 19–29 WT and 19–29
S20G.
Cytotoxicity assays
HEK293 cells and Rin5F cells were plated at 10,000 and 27,000 cells per well in 90 mL, respectively,
in 96-well plates (Cat. # 3596, Costar, Tewksbury, MA). Cells were allowed to adhere to the plate for
20–24 hr.
For the assay in Figures 1 and 50 mM full-length IAPP was aged in vitro for the designated incu-
bation times. To generate the soluble and insoluble fractions, the ‘hIAPP 24 h’ preparation was cen-
trifuged at 21,000xg for 45 min and then the supernatant, which is the soluble fraction, was carefully
removed and transferred to a 0.1 mm spin filter tube. Next, the supernatant was filtered and the pel-
leted material, which is the insoluble fraction, was resuspended in the original total volume.
For the assays in Figure 5 and Figure 5—figure supplement 2, 1 mM spine segment and 100
mM full-length IAPP samples were generated by preparing the samples as described previously and
then incubating them for 15 hr at room temperature under quiescent conditions. After the incuba-
tion period, the spine segments were diluted appropriately.
For all assays, 10 mL of sample was added to cells. By doing this, samples were diluted 1/10 from
in vitro stocks. Experiments were done in triplicate.
The appropriate statistical test for significance was determined by assessing whether (1) The sam-
ple sets had a Gaussian distribution using a D’Agostino-Pearson omnibus normality test and (2) The
sample sets had equal variance using a Bartlett’s test or F test. For samples with Gaussian distribu-
tions and equal variances, we employed an unpaired t-test with equal standard deviations. For sam-
ples with Gaussian distributions, but unequal variances, we employed an unpaired t-test with
Welch’s correction. For samples with non-Gaussian distributions and unequal variances, we
employed a Mann-Whitney U-test.
3-(4,5-dimethylthiazol-2-yl) 2,5-diphenyltetrazolium bromide (MTT) dye
reduction assay for cell viability
After a 24 hr incubation of samples with cells, 20 mL of Thiazolyl Blue Tetrazolium Bromide MTT dye
(Sigma, St. Louis, MO) was added to each well and incubated for 3.5 h at 37˚C under sterile condi-
tions. The MTT dye stock is 5 mg/mL in Dulbecco’s PBS. Next, the plate was removed from the incu-
bator and 100 mL of MTT stop solution (Cat. #4101, Promega, Madison, WI) was added to each well.
We ensured the MTT crystals were fully dissolved by placing the plates on an orbital shaker (slow
speed) for about an hour prior to taking measurements. Alternatively, the MTT assay was stopped
by carefully aspirating off the culture media and adding 100 mL of 100% DMSO to each well. Absor-
bance was measured at 570 nm using a SpectraMax M5. A background reading was recorded at 700
nm and subsequently subtracted from the 570 nm value.
Cells treated with vehicle alone (PBS + 0.1% DMSO) were designated at 100% viable, and cell via-
bility of all other treatments was calculated accordingly.
For the MTT reduction assay in Figure 6, a single data point from the mIAPP sample set was
deemed an outlier based on 2 lines of evidence: (1) The data point was identified as an outlier using
a Grubb’s test (a = 0.1) for outliers using the n = 9 sample set, and (2) When the sample set was
pooled with more data collected for different experiments (n = 42), the data point was identified as
an outlier using a more stringent Grubb’s test (a = 0.01).
Caspase-3/7 activation assay
We used the caspase-3/7 GLO assay (Cat. # G8091, Promega, Madison, WI) to detect caspase-3/7
activation. For this assay, Rin5F cells were plated as previously described in white-walled 96-well
plates (Cat. # 3917, Costar, Tewksbury, MA). After the designated aging period of each hIAPP prep-
aration, 10 mL of sample was added to cells and thus diluted 1/10 from in vitro stocks. Experiments
were performed in triplicate. Samples were incubated with cells for 24 h. Next, cell culture media,
caspase-3/7 reagent, and the cells were brought to room temperature. All media was aspirated from
wells and then replaced with 25 mL of media and 25 mL of caspase-3/7 reagent and mixed thor-
oughly. The plate was incubated at room temperature for 30 min and then luminescence was
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measured using a SpectraMax M5. Experimental points were normalized to vehicle-treated cells,
which were designated as 100%. Cells treated with 2 mM staurosporine were used as a positive con-
trol to ensure the assay kit worked correctly.
FRET-based real-time monitoring of caspase-3 activity
CHO cells were stably transfected with a vector producing EYFP and ECFP connected via a short
linker containing the Asp-Glu-Val-Asp (DEVD) sequence targeted by activated caspase-3. The short
linker allows fluorescence energy transfer (FRET) to occur between the two fluorophores. During
apoptosis activated caspase-3 cleaves the linker resulting in a loss of FRET measured as a reduced
540 nm/480 nm emission ratio.
Cells were plated at 25,000 cells per well in black 96-well optical bottom plates (Nunc, Grand
Island, NY) and the assay was performed in Krebs-Ringer (120 mM NaCl, 4.7 mM KCl, 2.5 mM
CaCl2, 1.2 mM MgSO4, 0.5 mM KH2PO4, pH 7.4) supplemented with 20 mM HEPES and 2 mM glu-
cose (KRHG).
hIAPP peptides (1–37, 15–25 WT and S20G, 19–29 WT and S20G) (final peptide concentration 50
mM in 1% DMSO) were mixed with sonicated, preformed fibrils (seeds) made of the same peptide
(corresponding to 166 nM of monomers) and immediately added to the plated cells. FRET was moni-
tored in real-time by measuring emission at 480 nm and 540 nm with 440 nm excitation in a FLUOs-
tar Omega microplate reader (BMG Labtech) over 24 hr at 37˚C.
SDS sensitivity assay
Fibrils of 15–25 WT and 19–29 S20G at monomer equivalent concentrations were allowed to form
for one week to ensure complete fibril formation. The samples were homogenized with vortexing,
and then aliquoted to 0.5 mL tubes with equal volumes. Each fibril sample was treated with water or
increasing amounts of SDS, and then heated at 55˚C for 20 min. Next, an aliquot of each sample was
transferred to a 384-well plate and turbidity was measured by recording absorbance at 340 nm.
Each fibril sample was spotted onto a grid for negative-stain EM to analyze fibril abundance. The
experiment was repeated twice, but the results of 1 experiment are shown in Figure 4—figure sup-
plement 1.
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